Clinical trial footprint Serving over 75 clinical trials in Psychiatry/Neurology/Sleep indicates a strong track record in neuro-focused data collection and analysis, suggesting continued demand for advanced electrophysiological data services and potential expansion into related CNS indications.

Niche data services Specializes in quality controlled data collection, quantitative analysis, data management, statistics, and publication support, presenting cross-sell opportunities to CROs, biotechs, and hospitals needing end-to-end analytical and reporting capabilities.

Mid-market potential With 11-50 employees and annual revenue in the lower-mid range, Q-Metrx sits between boutique firms and large analytics providers, offering opportunities for value-based partnerships, bundled services, and scalable engagement models.

Tech stack leverage Utilizes cloud and web technologies (Google Cloud, Site5, Font Awesome, Modernizr) which can be positioned for secure, scalable data management and integrated analytics solutions, including compliant data hosting and reproducible workflows.

Growth indicators Experience with numerous clinical trials and a clear focus on quality-controlled electrophysiological data positions Q-Metrx as a potential client for software and services that enhance study efficiency, regulatory submission readiness, and publication impact.